These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21134341)

  • 1. Differences in glycemic control and survival predict higher ESRD rates in diabetic First Nations adults.
    Dyck RF; Sidhu N; Klomp H; Cascagnette PJ; Teare GF
    Clin Invest Med; 2010 Dec; 33(6):E390-7. PubMed ID: 21134341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.
    Jiang Y; Osgood N; Lim HJ; Stang MR; Dyck R
    CMAJ; 2014 Feb; 186(2):103-9. PubMed ID: 24295857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach.
    Gao A; Osgood ND; Jiang Y; Dyck RF
    BMC Nephrol; 2017 Sep; 18(1):283. PubMed ID: 28870154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): An Emerging Relationship With Pregestational Diabetes Mellitus Among First Nations and Non-First Nations People in Saskatchewan-Results From the DIP: ORRIIGENSS Project.
    Dyck RF; Karunanayake C; Pahwa P; Stang M; Erickson RL; Osgood ND
    Can J Diabetes; 2021 Jun; 45(4):346-354.e1. PubMed ID: 33308984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
    Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
    Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-diabetic end-stage renal disease among Saskatchewan aboriginal people.
    Dyck RF; Tan L
    Clin Invest Med; 1998 Feb; 21(1):33-8. PubMed ID: 9512883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED; Patel S
    Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.
    Dyck RF; Tan L
    CMAJ; 1994 Jan; 150(2):203-8. PubMed ID: 8287342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring quality of diabetes care by linking health care system administrative databases with laboratory data.
    Klomp H; Dyck RF; Sidhu N; Cascagnette PJ; Teare GF
    BMC Res Notes; 2010 Aug; 3():233. PubMed ID: 20807443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease.
    Limkunakul C; de Boer IH; Kestenbaum BR; Himmelfarb J; Ikizler TA; Robinson-Cohen C
    J Diabetes Complications; 2019 Apr; 33(4):296-301. PubMed ID: 30795915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of care for First Nations and non-First Nations People with diabetes.
    Deved V; Jette N; Quan H; Tonelli M; Manns B; Soo A; Barnabe C; Hemmelgarn BR;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1188-94. PubMed ID: 23449766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study.
    Landray MJ; Emberson JR; Blackwell L; Dasgupta T; Zakeri R; Morgan MD; Ferro CJ; Vickery S; Ayrton P; Nair D; Dalton RN; Lamb EJ; Baigent C; Townend JN; Wheeler DC
    Am J Kidney Dis; 2010 Dec; 56(6):1082-94. PubMed ID: 21035932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated haemoglobin and the incidence of end-stage renal disease in diabetics.
    Oh SW; Kim YC; Koo HS; Jin DC; Na KY; Chae DW; Kim S; Chin HJ
    Nephrol Dial Transplant; 2011 Jul; 26(7):2238-44. PubMed ID: 21098657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glycosylated hemoglobin level and 16-year incidence of chronic kidney disease in type 1 diabetes.
    Shankar A; Klein R; Klein BE; Moss SE
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):203-6. PubMed ID: 17427112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and burnt-out diabetes in ESRD.
    Kovesdy CP; Park JC; Kalantar-Zadeh K
    Semin Dial; 2010; 23(2):148-56. PubMed ID: 20374552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
    Hallan SI; Rifkin DE; Potok OA; Katz R; Langlo KA; Bansal N; Ix JH
    Kidney Int; 2019 Sep; 96(3):728-737. PubMed ID: 31301887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
    Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
    Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.